SALEM, N.H., Nov. 16 /PRNewswire/ -- AgaMatrix, Inc., a privately held
developer and manufacturer of blood glucose monitoring products, has
received clearance from the United States Food and Drug Administration
("FDA") to sell its Zero-Click(TM) Blood Glucose Data Management System
("Zero-Click"). Zero-Click makes it easier for users to download and manage
data from AgaMatrix's blood glucose monitoring systems ("BGMS").
This data management product is the only system in the world featuring
Zero-Click technology, which enables users to effortlessly download data
via a USB style connection by simply connecting a BGMS to a computer. No
keyboard or mouse clicks are required for a user to be able to view or
download data from their meter, much in the same way that a computer
automatically detects and plays audio CDs.
Zero-Click can be operated in two modes: a home user mode optimized for
ease-of-use for self-testers and a professional mode designed for more
advanced users and multi-patient support by health care providers.
The software also uniquely features proprietary Virtual Meter(TM)
technology, which enables users to quickly update numerous settings on
their BGMS directly from their computer, without having to navigate through
difficult menus on their meter.
Zero-Click supports all meters Powered By WaveSense(TM), including the
WaveSense(TM) KeyNote(TM) BGMS (sold in the US), the Liberty(TM)-branded
BGMS (sold in the US), the iTest(TM) BGMS (sold in Canada), the Wellion(TM)
Linus(TM) BGMS (sold in Europe), the GracePro(TM) BGMS (sold in China), and
other Wave 1(TM) products sold throughout the world.
"Zero-Click was designed from the ground up with the user in mind.
Users simply have to plug in their meter to their computer and Zero-Click
does the rest. At the clinic, care providers no longer have to fumble
around with a mess of wires while trying to find the serial port and then
attempting to figure out which program on their desktop to click on," said
Sonny Vu, EVP of Business Development and Marketing at AgaMatrix.
AgaMatrix continues to find private label partners in other sales
channels in the US and abroad for Zero-Click, as well as AgaMatrix's other
Other major makers of BGMS software to serve the $6 billion BGMS market
include Roche, Johnson and Johnson, Bayer, and Abbott.
AgaMatrix, Inc. (www.agamatrix.com) is a consumer medical device
company headquartered in Salem, New Hampshire that develops and
manufactures next generation blood glucose monitoring products for the
diabetes market. The Company's proprietary WaveSense(TM) platform, a suite
of biosensor and Dynamic Electrochemistry(TM) technologies, enables high
accuracy glucose sensing. Current products include a meter and strip
system; future products include a cartridge-based system that fully
integrates lancets and sensors.
Powered By WaveSense(TM), WaveSense(TM), Wave 1(TM), KeyNote(TM),
Zero-Click(TM), Virtual Meter(TM), and their respective logos are
trademarks of AgaMatrix, Inc. Registered trademarks are the property of
their respective owners.
SOURCE AgaMatrix, Inc.